Bone Marrow Involvement in Patients with Type 1 Gaucher Disease Receiving Low-Dose Long Term Enzyme Replacement Therapy (median 18 years)

被引：0
|
作者：
Revel-Vilk, Shoshana [1 ,2 ]
Szer, Jeffrey [3 ,4 ]
Cohen, Michal Becker [1 ]
Zimran, Ari [1 ,2 ]
机构：
[1] Shaare Zedek Med Ctr, Gaucher Unit, Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Facul Med, Jerusalem, Israel
[3] Royal Melbourne Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[4] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-131013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4862
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The Bone Biomarker of Quantitative Chemical Shift Imaging in Patients with Type 1 Gaucher Disease Receiving Low-Dose Long-Term Enzyme Replacement Therapy
    Zimran, Ari
    Szer, Jeff
    Becker-Cohen, Michal
    Jens, Sjoerd
    Cozma, Claudia
    Revel-Vilk, Shoshana
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [2] Bone Marrow Alteration in Patients With Type 1 Gaucher Disease on Enzyme Replacement Therapy
    Lerner, D.
    Simpson, W.
    Hermann, G.
    Balwani, M.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (05)
  • [3] Markers of bone turnover in patients with type 1 Gaucher disease receiving long-term velaglucerase alfa enzyme replacement therapy
    Zimran, Ari
    Mehta, Atul
    Gonzalez, Derlis E.
    Ben Dridi, Marie-Francoise
    Lukina, Elena A.
    Chang, Peter
    Olivier, Clement
    Elstein, Deborah
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S129 - S130
  • [4] Effect of low-dose enzyme replacement therapy on bones in Gaucher disease patients with severe skeletal involvement
    Elstein, D
    HadasHalpern, I
    Itzchaki, M
    Lahad, A
    Abrahamov, A
    Zimran, A
    BLOOD CELLS MOLECULES AND DISEASES, 1996, 22 (11) : 104 - 111
  • [5] Effect of low-dose enzyme replacement therapy on bones in Gaucher disease patients with severe skeletal involvement - Commentary
    Beutler, E
    BLOOD CELLS MOLECULES AND DISEASES, 1996, 22 (11) : 113 - 114
  • [6] Low-dose enzyme replacement therapy for Gaucher disease: a case report
    Alegra, T.
    Krug, B.
    Oliveira, F.
    Pinto, L. L. C.
    Wanderley, H. Y.
    Todeschini, L. A.
    Picon, P.
    Schwartz, I. V.
    ACTA PAEDIATRICA, 2008, 97 : 116 - 116
  • [7] Low dose enzyme replacement therapy in paediatric type 1 Gaucher's disease
    Bembi, B
    Donda, MG
    Martini, C
    Zanatta, M
    Boscolo, R
    Katouzian, F
    Ciana, G
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1998, 24 (01): : 93 - 98
  • [8] CORRECTION OF NEUTROPHIL CHEMOTAXIS DEFECT IN PATIENTS WITH GAUCHER DISEASE BY LOW-DOSE ENZYME REPLACEMENT THERAPY
    ZIMRAN, A
    ABRAHAMOV, A
    AKER, M
    MATZNER, Y
    AMERICAN JOURNAL OF HEMATOLOGY, 1993, 43 (01) : 69 - 71
  • [9] Low-dose low-frequency imiglucerase as a starting regimen of enzyme replacement therapy for patients with type I Gaucher disease
    Elstein, D
    Abrahamov, A
    Hadas-Halpern, I
    Meyer, A
    Zimran, A
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1998, 91 (07): : 483 - 488
  • [10] Bone marrow involvement in Gaucher disease at MRI : what long-term evolution can we expect under enzyme replacement therapy?
    Fedida, Benjamin
    Touraine, Sebastien
    Stirnemann, Jerome
    Belmatoug, Nadia
    Laredo, Jean-Denis
    Petrover, David
    EUROPEAN RADIOLOGY, 2015, 25 (10) : 2969 - 2975
12345